Adaptive Biotechnologies Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +19.1% | +48.6% | +0.0% | -26.3% | +74.8% | +17.7% | -7.1% | -13.6% | +0.4% | +25.3% | +14.8% | +27.4% | +0.2% | +2.5% | -3.9% | +1.8% | +13.1% | +9.6% | +15.4% | -31.8% | +30.0% | -22.5% | +20.7% | -8.5% | +3.1% | +7.5% | +2.2% | +10.5% | +12.3% | +59.6% | -23.7% | -1.1% | +1.0% | – | |
| – | +26.4% | +6.3% | -1.6% | -5.4% | +15.0% | -2.3% | +6.2% | -10.2% | -8.1% | +23.2% | +2.8% | +60.6% | +7.7% | +31.8% | +1.2% | -8.1% | +0.2% | +12.8% | +11.3% | +12.6% | -4.1% | +8.0% | +1.4% | -8.0% | +7.0% | -13.7% | +8.3% | -5.9% | +6.0% | +0.9% | +0.4% | +2.7% | +10.0% | – | |
| – | +13.9% | +81.3% | +0.8% | -35.6% | +113.6% | +24.7% | -10.7% | -14.7% | +3.3% | +25.9% | +18.4% | +18.7% | -2.5% | -8.9% | -6.7% | +7.9% | +19.7% | +8.2% | +17.3% | -50.9% | +63.5% | -40.1% | +40.9% | -9.0% | +0.2% | +24.7% | -1.2% | +20.6% | +15.3% | +85.5% | -29.5% | -2.4% | -2.3% | – | |
| – | +6.7% | +3.5% | +13.1% | +12.8% | +32.4% | +24.1% | +3.3% | +13.0% | +8.6% | +16.6% | +18.2% | -5.7% | +11.9% | -4.6% | -3.8% | +9.0% | -2.1% | -3.7% | -12.4% | +4.4% | -1.1% | -11.5% | +0.7% | +5.2% | -16.2% | -4.7% | -4.0% | +4.4% | -0.3% | -1.9% | -8.1% | +8.5% | -18.9% | – | |
| – | +2.0% | +2.3% | +37.1% | +7.8% | -4.9% | +27.2% | -3.4% | +44.4% | +3.5% | -1.3% | +10.9% | +11.5% | +7.6% | +25.4% | +15.8% | +3.4% | -12.2% | -2.1% | +8.1% | -7.1% | +7.1% | -10.0% | +3.2% | -5.4% | -8.7% | -3.6% | +4.6% | -3.6% | +2.2% | +1.0% | +8.9% | +7.3% | +0.9% | – | |
| – | +5.2% | +5.8% | +24.2% | +6.4% | +17.3% | +18.5% | +10.2% | +18.2% | +5.6% | +8.1% | +19.0% | +2.2% | +11.1% | +5.3% | +4.4% | +3.9% | -6.3% | -5.5% | -0.7% | -2.1% | +3.5% | -11.8% | +39.8% | -25.4% | -1.9% | -12.3% | +1.4% | +2.9% | +1.3% | -0.6% | +1.1% | +7.8% | -6.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -224.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +54.2% | +56.2% | +449.0% | -1.5% | +2.1% | +1.3% | -17.5% | -0.6% | -9.9% | +9.0% | +0.4% | -1.6% | +1.5% | +0.8% | -0.6% | -2.2% | -6.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -242.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +62.2% | -255.2% | – | – | – | – | – | – | -2,252.3% | – | -10.5% | -259.6% | – | – | -100.6% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -242.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -138.0% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.